Abstract
A new wave of rapid and accurate molecular diagnostics, which harness the power of genomics and proteomics, hold great potential to improve aspects of maternal health on a global scale. This review will provide a context to issues related to global maternal health and highlight international endeavors aimed to alleviate morbidity and mortality during pregnancy, childbirth and into the postnatal period. The authors will couple these efforts to actionable and promising theranostic advancements in the detection and treatment of HIV and malaria through the lens of maternal global health strategies.
Acknowledgements
P Madadi wrote this manuscript and is responsible for all content and viewpoints that are expressed within it. EFO Enato was consulted for his expertise in the management and treatment of malaria during pregnancy and contributed substantially to the intellectual content in this section. A Walfisch was consulted for her obstetrical and clinical expertise, and provided particular insight on the treatment and management of HIV during pregnancy. All authors critically reviewed the manuscript prior to submission.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.